Insider Transactions in Q2 2025 at Lexeo Therapeutics, Inc. (LXEO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2025
|
Tai Sandi See Chief Development Officer |
SELL
Open market or private sale
|
Direct |
367
-0.62%
|
$734
$2.77 P/Share
|
|
May 16
2025
|
Jenny Robertson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
521
-0.82%
|
$1,042
$2.77 P/Share
|
|
May 16
2025
|
Eric Adler Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
585
-0.86%
|
$1,170
$2.77 P/Share
|
|
May 16
2025
|
Richard Nolan Townsend Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,074
-0.48%
|
$2,148
$2.77 P/Share
|